The present invention relates to identification new peptides to be related to (T1D) of type 1 diabetes from paraprotein, also referred to as defective ribosomal product (DRiPs). Particularly, be present in peoples proinsulin original in (PPI) mRNA the present invention relates to DRiPs epitopes, representative peptide and its in diagnosis, prevention and/or treatment T1D. Moreover, invention is related to antibody and antiserum to the epitope of identification and its diagnosis T1D.
